These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 32075016)
1. Serum Sclerostin But Not DKK-1 Correlated with Central Arterial Stiffness in End Stage Renal Disease Patients. Wu CF; Hou JS; Wang CH; Lin YL; Lai YH; Kuo CH; Liou HH; Tsai JP; Hsu BG Int J Environ Res Public Health; 2020 Feb; 17(4):. PubMed ID: 32075016 [TBL] [Abstract][Full Text] [Related]
2. Increased Sclerostin, but Not Dickkopf-1 Protein, Is Associated with Elevated Pulse Wave Velocity in Hemodialysis Subjects. Stavrinou E; Sarafidis PA; Koumaras C; Loutradis C; Giamalis P; Tziomalos K; Karagiannis A; Papagianni A Kidney Blood Press Res; 2019; 44(4):679-689. PubMed ID: 31382263 [TBL] [Abstract][Full Text] [Related]
3. Serum levels of sclerostin as a potential biomarker in central arterial stiffness among hypertensive patients. Chang YC; Hsu BG; Liou HH; Lee CJ; Wang JH BMC Cardiovasc Disord; 2018 Nov; 18(1):214. PubMed ID: 30482161 [TBL] [Abstract][Full Text] [Related]
4. Serum osteoprotegerin is an independent marker of central arterial stiffness as assessed using carotid-femoral pulse wave velocity in hemodialysis patients: a cross sectional study. Hou JS; Lin YL; Wang CH; Lai YH; Kuo CH; Subeq YM; Hsu BG BMC Nephrol; 2019 May; 20(1):184. PubMed ID: 31122190 [TBL] [Abstract][Full Text] [Related]
5. Serum Sclerostin as an Independent Marker of Peripheral Arterial Stiffness in Renal Transplantation Recipients: A Cross-Sectional Study. Hsu BG; Liou HH; Lee CJ; Chen YC; Ho GJ; Lee MC Medicine (Baltimore); 2016 Apr; 95(15):e3300. PubMed ID: 27082570 [TBL] [Abstract][Full Text] [Related]
6. Correlation between sclerostin and Dickkopf-1 with aortic arterial stiffness in patients with type 2 diabetes: A prospective, cross-sectional study. Yang HY; Wu DA; Chen MC; Hsu BG Diab Vasc Dis Res; 2019 May; 16(3):281-288. PubMed ID: 30547685 [TBL] [Abstract][Full Text] [Related]
7. The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women. Hampson G; Edwards S; Conroy S; Blake GM; Fogelman I; Frost ML Bone; 2013 Sep; 56(1):42-7. PubMed ID: 23702386 [TBL] [Abstract][Full Text] [Related]
8. Circulating sclerostin and Dickkopf-1 (DKK1) in predialysis chronic kidney disease (CKD): relationship with bone density and arterial stiffness. Thambiah S; Roplekar R; Manghat P; Fogelman I; Fraser WD; Goldsmith D; Hampson G Calcif Tissue Int; 2012 Jun; 90(6):473-80. PubMed ID: 22527202 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of Arterial Stiffness and Associated Factors in Thai Patients with Chronic Kidney Disease and Kidney Transplant Recipients. Thanakitcharu P; Jitsuparat Y; Jirajan B J Med Assoc Thai; 2017 Feb; 100 Suppl 1():S56-69. PubMed ID: 29927191 [TBL] [Abstract][Full Text] [Related]
10. Serum Malondialdehyde-Modified Low-Density Lipoprotein Is a Risk Factor for Central Arterial Stiffness in Maintenance Hemodialysis Patients. Hou JS; Wang CH; Lai YH; Kuo CH; Lin YL; Hsu BG; Tsai JP Nutrients; 2020 Jul; 12(7):. PubMed ID: 32708072 [TBL] [Abstract][Full Text] [Related]
11. Serum Lai YH; Wang CH; Kuo CH; Lin YL; Tsai JP; Hsu BG Toxins (Basel); 2019 Dec; 12(1):. PubMed ID: 31877718 [TBL] [Abstract][Full Text] [Related]
12. Volume status and arterial blood pressures are associated with arterial stiffness in hemodialysis patients. Erdan A; Ozkok A; Alpay N; Akkaya V; Yildiz A Int J Artif Organs; 2018 Jul; 41(7):378-384. PubMed ID: 29806514 [TBL] [Abstract][Full Text] [Related]
13. The serum sclerostin level is positively associated with the aortic augmentation index in patients on peritoneal dialysis. Lin L; Lai YH; Chiu LT; Tsai JP; Wang CH; Hsu BG Tzu Chi Med J; 2019; 31(2):102-106. PubMed ID: 31007490 [TBL] [Abstract][Full Text] [Related]
14. Factors associated with serum soluble inhibitors of Wnt-β-catenin signaling (sclerostin and dickkopf-1) in patients undergoing peritoneal dialysis. Yamada S; Tsuruya K; Tokumoto M; Yoshida H; Ooboshi H; Kitazono T Nephrology (Carlton); 2015 Sep; 20(9):639-45. PubMed ID: 25974190 [TBL] [Abstract][Full Text] [Related]
15. Serum Endocan Is a Risk Factor for Aortic Stiffness in Patients Undergoing Maintenance Hemodialysis. Wu TJ; Wang CH; Lai YH; Kuo CH; Lin YL; Hsu BG Medicina (Kaunas); 2024 Jun; 60(6):. PubMed ID: 38929601 [No Abstract] [Full Text] [Related]
16. FGF23-klotho axis, bone fractures, and arterial stiffness in dialysis: a case-control study. Desbiens LC; Sidibé A; Ung RV; Fortier C; Munger M; Wang YP; Bisson SK; Marquis K; Agharazii M; Mac-Way F Osteoporos Int; 2018 Oct; 29(10):2345-2353. PubMed ID: 29959497 [TBL] [Abstract][Full Text] [Related]
17. Serum Osteopontin Level Is Positively Associated with Aortic Stiffness in Patients with Peritoneal Dialysis. Chang KH; Wang CH; Hsu BG; Tsai JP Life (Basel); 2022 Mar; 12(3):. PubMed ID: 35330148 [TBL] [Abstract][Full Text] [Related]
18. Positive Associations between Adipocyte Fatty Acid-Binding Protein Level and Central Arterial Stiffness in Peritoneal Dialysis Patients. Sung CH; Hsu BG; Tasi JP; Wang CH; Kuo CH Int J Hypertens; 2021; 2021():8849115. PubMed ID: 33628486 [TBL] [Abstract][Full Text] [Related]
19. Hyperleptinemia positively associated with central arterial stiffness in hemodialysis patients. Kuo CH; Lin YL; Lee CJ; Wang CH; Lai YH; Liou HH; Hsu BG PLoS One; 2018; 13(1):e0190694. PubMed ID: 29304064 [TBL] [Abstract][Full Text] [Related]